Monday, January 23, 2017 8:26:17 PM
codeine/ acetaminophen --
codeine/ acetaminophen Tylenol w/Codeine
codeine/ acetaminophen/ caffeine/ butalbital Fioricet w/Codeine
codeine/ asa --
codeine/ asa/ caffeine/ butalbital Fiorinal w/Codeine
fentanyl Abstral
fentanyl --
fentanyl Actiq
fentanyl Fentora
fentanyl, film Onsolis
fentanyl, nasal spray Lazanda
fentanyl, sublingual spray Subsys
fentanyl, transdermal --
fentanyl, transdermal Duragesic
hydrocodone/ acetaminophen --
hydrocodone/ acetaminophen Anexsia
hydrocodone/ acetaminophen Lorcet
hydrocodone/ acetaminophen Lortab
hydrocodone/ acetaminophen Norco
hydrocodone bitartrate Zohydro ER
hydrocodone/ ibuprofen --
hydrocodone/ ibuprofen Vicoprofen
hydromorphone --
hydromorphone Dilaudid
levorphanol --
levorphanol Levo-Dromoran
meperidine --
meperidine Demerol
methadone --
methadone Dolophine
morphine sulfate --
morphine sulfate MSIR
morphine sulfate, controlled release --
morphine sulfate, controlled release Avinza
morphine sulfate, controlled release Kadian
morphine sulfate, controlled release MS Contin
opium tincture, deodorized --
oxycodone --
oxycodone OxyIR
oxycodone, controlled release --
oxycodone, controlled release Oxycontin
oxycodone, extended release Xtampza ER
oxycodone/ acetaminophen --
oxycodone/ acetaminophen Percocet
oxycodone/ acetaminophen Tylox
oxycodone/acetaminophen Xartemis XR
oxycodone/ asa --
oxycodone/ asa Percodan
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 09:15:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/29/2023 08:43:45 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM